Areas of interest

Health economics, real-world evidence, precision medicine, causal inference, discrete choice experiments

Biography

Deirdre Weymann is a Staff Scientist and Director of Real World Evidence in the Regulatory Science Lab at BC Cancer, within British Columbia’s Provincial Health Services Authority. She is a leader in real-world data, quasi-experimental study design, and life-cycle assessment of health technologies. Deirdre holds a Master’s degree in Economics from the University of Victoria and a Bachelor of Science in Economics, Mathematics and Statistics from the University of British Columbia. She collaborates widely in national and international networks, including the Canadian Network for Learning Healthcare Systems and Cost-Effective ‘Omics Innovations (CLEO), Terry Fox Research Institute Marathon of Hope Cancer Centres Network (TFRI MOHCCN), International Health Economics Association Econ-Omics Special Interest Group, and Global Economics and Evaluation of Clinical Genomics Sequencing Working Group (GEECS). Deirdre has published in leading journals, including JAMA, Lancet Oncology, npj Precision Oncology, and Value in Health. Deirdre’s research identifies patient-valued outcomes for precision medicine; applies data science techniques to mitigate bias for real-world evidence; and advances quasi-experimental approaches for causal inference.